Validity of the modified Rankin Scale in patients with aneurysmal subarachnoid hemorrhage: a randomized study

E Nobels-Janssen,EN Postma,IL Abma,JMC van Dijk,IR de Ridder,H Schenck,WA Moojen,MH den Hertog,D Nanda,ARE Potgieser,BA Coert,WIM Verhagen,RHMA Bartels,PJ van der Wees,D Verbaan,HD Boogaarts
DOI: https://doi.org/10.1186/s12883-023-03479-x
2024-01-14
BMC Neurology
Abstract:The modified Rankin Scale (mRS), a clinician-reported outcome measure of global disability, has never been validated in patients with aneurysmal subarachnoid hemorrhage (aSAH). The aims of this study are to assess: (1) convergent validity of the mRS; (2) responsiveness of the mRS; and (3) the distribution of mRS scores across patient-reported outcome measures (PROMs).
clinical neurology
What problem does this paper attempt to address?